These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer. Sgouros G J Nucl Med; 2005 May; 46(5):899-900; author reply 901. PubMed ID: 15872367 [No Abstract] [Full Text] [Related]
11. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499 [TBL] [Abstract][Full Text] [Related]
12. Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma. Luster M; Sherman SI; Skarulis MC; Reynolds JR; Lassmann M; Hänscheid H; Reiners C Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1371-7. PubMed ID: 12856155 [TBL] [Abstract][Full Text] [Related]
13. [Lithium as an adjuvant in the radioiodine therapy of thyroid cancer]. Schraube P; Kimmig B; zum Winkel K Nuklearmedizin; 1984 Jun; 23(3):151-4. PubMed ID: 6435095 [TBL] [Abstract][Full Text] [Related]
15. How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer. Schlumberger M; Ricard M; De Pouvourville G; Pacini F Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):641-50. PubMed ID: 17710085 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine. Robbins RJ; Driedger A; Magner J; Thyroid; 2006 Nov; 16(11):1121-30. PubMed ID: 17123339 [TBL] [Abstract][Full Text] [Related]
17. Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH. Lassmann M; Hänscheid H; Reiners C; Thomas SR J Nucl Med; 2005 May; 46(5):900-1; author reply 901. PubMed ID: 15872369 [No Abstract] [Full Text] [Related]
18. Radioiodine in the treatment of thyroid disease. RAWSON RW Surg Gynecol Obstet; 1953 Jan; 96(1):118-20. PubMed ID: 13015359 [No Abstract] [Full Text] [Related]
19. Approach to the patient with advanced differentiated thyroid cancer. Schlumberger M; Sherman SI Eur J Endocrinol; 2012 Jan; 166(1):5-11. PubMed ID: 21890651 [TBL] [Abstract][Full Text] [Related]
20. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Jarzab B; Handkiewicz-Junak D; Wloch J Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]